Nkarta stock surged Monday — partially reversing a 31% dive on Friday — after unveiling promising test results for its lymphoma treatment.

The post Why Nkarta Stock Just Boomeranged Following A Massive Dive On Friday appeared first on Investor’s Business Daily.